Back to School: How biopharma can reboot drug development. Access exclusive analysis here

MX6: Began Phase II trial

Maxia Pharmaceuticals Inc., San Diego, Calif.
Product: MX6
Business:

Read the full 96 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE